Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances

Li, Luyao; Li, Jicui; Guan, Haifei; Oishi, Hisashi; Takahashi, Satoru; Zhang, Chuan

doi:10.7150/ijms.87472



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2023; 20(11):1492-1507. doi:10.7150/ijms.87472 This issue Cite

Review

Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances

Luyao Li¹, Jicui Li², Haifei Guan¹, Hisashi Oishi³, Satoru Takahashi⁴, Chuan Zhang^1,✉

1. Department of Endocrinology, the Second Hospital of Jilin University, Changchun 130041, Jilin, P.R. China.
2. Department of Nephrology, the Second Hospital of Jilin University, Changchun 130041, Jilin, P.R. China.
3. Department of Comparative and Experimental Medicine, Nagoya City University Graduate 24 School of Medical Sciences, Aichi 467-8601, Nagoya, Japan.
4. Institute of Basic Medical Sciences and Laboratory Animal Resource Center, University of Tsukuba, Ibaraki 305-8575, Tsukuba, Japan.

Citation:

Li L, Li J, Guan H, Oishi H, Takahashi S, Zhang C. Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. Int J Med Sci 2023; 20(11):1492-1507. doi:10.7150/ijms.87472. https://www.medsci.org/v20p1492.htm

Other styles

Abstract

Diabetes mellitus and its complications pose a major threat to global health and affect the quality of life and life expectancy of patients. Currently, the application of traditional therapeutic drugs for diabetes mellitus has great limitations and can only temporarily control blood glucose but not fundamentally cure it. Mesenchymal stem cells, as pluripotent stromal cells, have multidirectional differentiation potential, high self-renewal, immune regulation, and low immunogenicity, which provide a new idea and possible development direction for diabetes mellitus treatment. Regenerative medicine with mesenchymal stem cells treatment as the core treatment will become another treatment option for diabetes mellitus after traditional treatment. Recently, human umbilical cord mesenchymal stem cells have been widely used in basic and clinical research on diabetes mellitus and its complications because of their abundance, low ethical controversy, low risk of infection, and high proliferation and differentiation ability. This paper reviews the therapeutic role and mechanism of human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications and highlights the challenges faced by the clinical application of human umbilical cord mesenchymal stem cells to provide a more theoretical basis for the application of human umbilical cord mesenchymal stem cells in diabetes mellitus patients.

Keywords: umbilical cord, mesenchymal stem cells, diabetes mellitus, pluripotent, clinical application, regenerative medicine

Citation styles

APA

Li, L., Li, J., Guan, H., Oishi, H., Takahashi, S., Zhang, C. (2023). Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. International Journal of Medical Sciences, 20(11), 1492-1507. https://doi.org/10.7150/ijms.87472.

ACS

Li, L.; Li, J.; Guan, H.; Oishi, H.; Takahashi, S.; Zhang, C. Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. Int. J. Med. Sci. 2023, 20 (11), 1492-1507. DOI: 10.7150/ijms.87472.

NLM

CSE

Li L, Li J, Guan H, Oishi H, Takahashi S, Zhang C. 2023. Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. Int J Med Sci. 20(11):1492-1507.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.